Lisinopril

Anti-LIX1L limb and CNS expressed 1 like, 100ul UN 1687 6.1

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Lisinopril is a nonsulfhydryl angiotensin-converting enzyme (ACE) inhibitor. It is used in the treatment of heart failure and hypertension.

General description Lisinopril is a lysine derivative of enalaprilat and belongs to the group of angiotensin converting enzyme (ACE) inhibitors. It is widely used as an orally active medication in the treatment of high blood pressure and may be

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

A potent ACE inhibitor that blocks the formation of angiotensin I with an IC₅₀ value of 1.2 nM (ovine) and displays ID₅₀ values of 2.3 and 6.5 &microg/kg in rat and canine, respectively.

A potent ACE inhibitor that blocks the formation of angiotensin I with an IC₅₀ value of 1.2 nM (ovine) and displays ID₅₀ values of 2.3 and 6.5 &microg/kg in rat and canine, respectively.

A potent ACE inhibitor that blocks the formation of angiotensin I with an IC₅₀ value of 1.2 nM (ovine) and displays ID₅₀ values of 2.3 and 6.5 &microg/kg in rat and canine, respectively.

A potent ACE inhibitor that blocks the formation of angiotensin I with an IC₅₀ value of 1.2 nM (ovine) and displays ID₅₀ values of 2.3 and 6.5 &microg/kg in rat and canine, respectively.

HPLC column LiChrospher &#174 RP-8 is a reliable and versatile traditionally produced spherical silica gel carrier with C-8 reversed phase properties. It is well suited for the separation of neutral, acidic and weak basic compounds.